Skip to content

Member News Update from Lab Data Solutions LLC

Date: March 14, 2026

This news piece has been submitted by Lab Data Solutions LLC

We’re Attending US Summit 2026!

Lab Data Solutions LLC is pleased to announce that we will be attending the ACDM US Summit 2026, taking place May 18–19, 2026, in Princeton, New Jersey. Hosted by Genmab, this inaugural Summit marks an important milestone for the clinical data management community—and for us, it represents our first public appearance as a company.

The ACDM US Summit brings together leading voices in Clinical Data Management and the broader clinical research ecosystem to advance discussion, collaboration, and shared learning. Designed as a forum for both scientific and practical exchange, the Summit focuses on strengthening how data management supports trust, innovation, and impact across clinical research.

Under the theme “Clinical Data Management at the Heart: Driving Trust, Innovation, and Impact,” the programme includes thought‑leadership sessions, real‑world case discussions, and meaningful networking opportunities. The event will begin with a networking evening on May 18, followed by a full day of focused sessions and discussions on May 19.

As a company dedicated to supporting high‑quality lab data and reliable data review processes, Lab Data Solutions LLC values opportunities to engage directly with peers, sponsors, CROs, and data professionals who share a commitment to data integrity and operational excellence. The Summit’s emphasis on collaboration and inclusivity—welcoming participants from across the global ACDM community—aligns closely with our own approach to clinical data work.

We look forward to learning from industry leaders, contributing to conversations shaping the future of clinical data management, and building connections within the clinical research community. If you will be attending the ACDM US Summit 2026, we would welcome the opportunity to connect and exchange perspectives.

 


 

Explore More News

Newsletter Committee: Meet Federica

The ACDM is delighted to welcome Federica Migliore of IQVIA to the Newsletter . . .

Read More

Welcome P95 as a corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome P95 as a new . . .

Read More

AI Symposium Session Summary: Is AI in clinical trials delivering measurable ROI?

At the 4th Annual ACDM Symposium on Artificial Intelligence (AI) in Clinical Trials, the . . .

Read More

Newsletter Committee: Meet Neha

The ACDM is delighted to welcome Neha Shah of ITM to the Newsletter Committee. Neha shares . . .

Read More

Newsletter Committee: Meet Sylvain

The ACDM is delighted to welcome Sylvain Berthelot of CRScube to the Newsletter . . .

Read More

Welcome VHypotenuse as a corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome VHypotenuse as . . .

Read More

Newsletter Committee: Meet Marta

The ACDM is delighted to welcome Marta Kowalska of CluePoints to the Newsletter . . .

Read More

AI model trained on de-identified data from 57 million people

Researchers at UCL have trained an AI model using de-identified data from 57 million . . .

Read More

ACDM Regulatory Considerations DMEG Update: ICH E6 (R3) GCP Final Publication Released

The final publication of ICH E6 (R3) Good Clinical Practice (GCP) General Principles and . . .

Read More

ICH E6(R3) Guideline reaches Step 4 of the ICH Process

ICH E6(R3) reaches Step 4 of the ICH Process on 6th January 2025. The guideline . . .

Read More

U.S. Food & Drug Administration: Draft Guidance for Industry and Other Interested Parties

The U.S. Food and Drug Administration has issued its first guidance on the use of . . .

Read More

ACDM DMEG News: Regulatory Updates and Forthcoming Challenges for 2025

As 2024 draws to a close, the Regulatory Considerations Data Management Expert Group . . .

Read More